Page 178 - Fluorescence-guided cancer surgery

176
Chapter 10
23.
24.
25.
26.
27.
28.
29.
van Dam GM, Themelis G, Crane LM et al. Intraoperative tumor-speci c uorescence imaging in ovarian cancer by folate receptor- alpha targeting: rst in-human results. Nat Med 2011;17:1315-1319.
van Driel PB, van de Giessen M, Boonstra MC et al. Characterization and evaluation of the artemis camera for uorescence- guided cancer surgery. Mol Imaging Biol 2015;17:413-423.
Szebeni J. Complement activation-related pseudoallergy: a new class of drug- induced acute immune toxicity. Toxicology 2005;216:106-121.
Wu M, Gunning W, Ratnam M. Expression of folate receptor type alpha in relation to cell type, malignancy, and di erentiation in ovary, uterus, and cervix. Cancer Epidemiol Biomarkers Prev 1999;8:775-782.
Shen J, Hilgenbrink AR, Xia W et al. Folate receptor-beta constitutes a marker for human proin ammatory monocytes. J Leukoc Biol 2014;96:563-570.
O’Shannessy DJ, Somers EB, Wang LC, Wang H, Hsu R. Expression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers. J Ovarian Res 2015;8:29.
Puig-Kroger A, Sierra-Filardi E, Dominguez- Soto A et al. Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti- in ammatory/regulatory macrophages. Cancer Res 2009;69:9395-9403.
30. Kurahara H, Takao S, Kuwahata T et al. Clinical signi cance of folate receptor beta- expressing tumor-associated macrophages in pancreatic cancer. Ann Surg Oncol 2012;19:2264-2271.
31. Smith HA, Kang Y. The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl) 2013;91:411-429.
32. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009;9:239-252.
33. Lewis CE, Pollard JW. Distinct role of macrophages in di erent tumor microenvironments. Cancer Res 2006;66:605- 612.
34. Keereweer S, van Driel PB, Snoeks TJ et al. Optical image-guided cancer surgery: challenges and limitations. Clin Cancer Res 2013;19:3745-3754.
35. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med 2003;9:123-128.
36. Monici M. Cell and tissue auto uorescence research and diagnostic applications. Biotechnol Annu Rev 2005;11:227-256.
37. Monici M, Basile V, Romano G et al. Fibroblast auto uorescence in connective tissue disorders: a future tool for clinical and di erential diagnosis? J Biomed Opt 2008;13:054025.
38. Rosenthal EL, Warram JM, de BE et al. Safety and Tumor Speci city of Cetuximab- IRDye800 for Surgical Navigation in Head and Neck Cancer. Clin Cancer Res 2015;21:3658- 3666.